Modifying the release properties of liposomes toward personalized medicine

Journal of Pharmaceutical Sciences

Volumn 103, Issue 6, 2014, Pages 1851-1862

  Cipolla, David ^a,b   Wu, Huiying ^b   Gonda, Igor ^b   Eastman, Simon ^c   Redelmeier, Tom ^c   Chan, Hak Kim ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ARADIGM CORPORATION   (United States)

^c Northern Lipids Inc   (Canada)

Author keywords

aerosols; ciprofloxacin; controlled delivery; drug delivery; in vitro release; liposomes; nanoparticles; personalized medicine; surfactants

Indexed keywords

CIPROFLOXACIN; POLYSORBATE 20; POLYSORBATE 80; ANTIINFECTIVE AGENT; LIPOSOME;

ARTICLE; CENTRIFUGATION; CONTROLLED STUDY; DRUG FORMULATION; DRUG RELEASE; ENCAPSULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; LIGHT SCATTERING; LIPOSOMAL DELIVERY; PERSONALIZED MEDICINE; TRANSMISSION ELECTRON MICROSCOPY; CRYOELECTRON MICROSCOPY; SOLUBILITY;

ANTI-BACTERIAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIPROFLOXACIN; CRYOELECTRON MICROSCOPY; INDIVIDUALIZED MEDICINE; LIPOSOMES; SOLUBILITY;

EID: 84901253650     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23969     Document Type: Article

References (32)

1. Drummond DC, Noble CO, Hayes ME, Park JW, Kirpotin DB,. 2008. Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development. J Pharm Sci 97: 4696-4740.
2. Cipolla D, Gonda I, Chan HK,. 2013. Liposomal formulations for inhalation. Ther Deliv 4 (8): 1047-1072.
3. Cipolla D, Redelmeier T, Eastman S, Bruinenberg P, Gonda I,. 2011. Liposomes, niosomes and proniosomes-A critical update of their (commercial) development as inhaled products. In Respiratory drug delivery Europe 2011;, Dalby RN, Byron PR, Peart J, Suman JD, Farr SJ, Young PM, Eds. River Grove, Illinois: Davis Healthcare Int'l Publishing, pp 41-54.
4. Helenius A, Simons K,. 1975. Solubilization of membranes by detergents. Biochim Biophys Acta 415 (1): 29-79.
5. Lichtenberg D, Robson RJ, Dennis EA,. 1983. Solubilization of phospholipids by detergents. Structural and kinetic aspects. Biochim Biophys Acta 737 (2): 285-304.
6. Velluto D, Gasbarri C, Angelini G, Fontana A,. 2011. Use of simple kinetic and reaction-order measurements for the evaluation of the mechanism of surfactant-liposome interactions. J Phys Chem B 115 (25): 8130-8137.
7. Cho W, Wu SK, Yoon E, Lichtenbergova L,. 1999. Fluorometric phospholipase assays based on polymerized liposome substrates. Methods Mol Biol 109: 7-17.
8. Paternostre MT, Roux M, Rigaud JL,. 1988. Mechanisms of membrane protein insertion into liposomes during reconstitution procedures involving the use of detergents. 1. Solubilization of large unilamellar liposomes (prepared by reverse-phase evaporation) by triton X-100, octyl glucoside, and sodium cholate. Biochemistry 27 (8): 2668-2677.
9. Ribosa I, Garcia MT, Parra JL, Maza A, Sanchez-Leal J, Trullas C, Tsi A, Balaguer F, Pelejero C,. 1992. Physico-chemical modifications of liposome structures through interaction with surfactantsy. Int J Cosmet Sci 14 (3): 131-149.
10. Lasch J., 1995. Interaction of detergents with lipid vesicles. Biochim Biophys Acta 1241 (2): 269-292.
11. Deo N, Somasundaran P., 2003. Effects of sodium dodecyl sulfate on mixed liposome solubilization. Langmuir 19 (18): 7271-7275.
12. Almgren M, Edwards K, Karlsson G,. 2000. Cryo transmission electron microscopy of liposomes and related structures. Colloids Surf A Physicochem Eng Aspects 174 (1-2): 3-21.
13. Nagawa Y, Regen SL,. 1992. Surfactant-induced release from phosphatidylcholine vesicles. Regulation of rupture and leakage pathways by membrane packing. J Am Chem Soc 114 (5): 1668-1672.
14. Liu Y, Regen SL,. 1993. Control over vesicle rupture and leakage by membrane packing and by the aggregation state of an attacking surfactant. J Am Chem Soc 115 (2): 708-713.
15. Ruiz J, Goni FM, Alonso A,. 1988. Surfactant-induced release of liposomal contents. A survey of methods and results. Biochim Biophys Acta 937 (1): 127-134.
16. Memoli A, Annesini MC, Petralito S,. 1999. Surfactant-induced leakage from liposomes: A comparison among different lecithin vesicles. Int J Pharm 184 (2): 227-235.
17. Kraft JC, Freeling JP, Wang Z, Ho RJY,. 2014. Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems. J Pharm Sci 103 (1): 29-52.
18. Ong HX, Traini D, Cipolla D, Gonda I, Bebawy M, Agus H, Young PY,. 2012. Liposomal nanoparticles control the uptake of ciprofloxacin across respiratory epithelia. Pharm Res 29 (12): 3335-3346.
19. Yim D, Blanchard JD, Mudumba S, Eastman S, Manda K, Redelmeier T, Farr S,. 2006. The development of inhaled liposome-encapsulated ciprofloxacin to treat cystic fibrosis. In Respiratory drug delivery 2006;, Dalby RN, Byron PR, Peart J, Suman JD, Farr SJ, Eds. River Grove, Illinois: Davis Healthcare Int'l Publishing, pp 425-428.
20. Webb MS, Boman NL, Wiseman DJ, Saxon D, Sutton K, Wong KF, Logan P, Hope MJ,. 1998. Antibacterial efficacy against an in vivo Salmonella typhimurium infection model and pharmacokinetics of a liposomal ciprofloxacin formulation. Antimicrob Agents Chemother 42 (1): 45-52.
21. Cipolla D, Wu H, Eastman S, Redelmeier T, Gonda I, Chan H-K,. 2014. Development and characterization of an in vitro release assay for liposomal ciprofloxacin for inhalation. J Pharm Sci 103 (1): 314-327.
22. Cipolla D, Dayton F, Fulzele S, Gabatan E, Mudumba S, Yim D, Wu H, Zwolinski R,. 2010. Inhaled liposomal ciprofloxacin: In vitro properties and aerosol performance. In Respiratory drug delivery 2010;, Dalby RN, Byron PR, Peart J, Suman JD, Farr SJ, Young PM, Eds. River Grove, Illinois: Davis Healthcare Int'l Publishing, pp 409-414.
23. Edwards K, Johnsson M, Karlsson G, Silvinder M,. 1997. Effect of polyethyleneglycol-phospholipids on aggregate structure in preparations of small unilamellar liposomes. Biophys J 73 (1): 258-266.
24. Ghosh P, Singh UN,. 1992. Liposome shrinkage and swelling under osmotic-diffusional stress: Evaluation of kinetic parameters from spectrophotometric measurements. Biochim Biophys Acta 1110 (1): 88-96.
25. De Gier J, Mandersloot JG, Van Deenen LLM,. 1968. Lipid composition and permeability of liposomes. Biochim Biophys Acta 150 (4): 666-675.
26. Borochov A, Borochov H,. 1979. Increase in membrane fluidity in liposomes and plant protoplasts upon osmotic swelling. Biochim Biophys Acta 550 (3): 546-549.
27. Thoren PE, Soderman O, Engstron S, Von Corswant C,. 2007. Interactions of novel, nonhemolytic surfactants with phospholipid vesicles. Langmuir 23 (13): 6956-65.
28. Terzano C, Allegra L, Alhaique F, Marianecci C, Carafa M,. 2005. Non-phospholipid vesicles for pulmonary glucocorticoid delivery. Eur J Pharm Biopharm 59 (1): 57-62.
29. Desai TR, Finlay WH,. 2002. Nebulization of niosomal all-trans-retinoic acid: An inexpensive alternative to conventional liposomes. Int J Pharm 241 (2): 311-317.
30. Elhissi A, Hidayat K, Phoenix DA, Mwesigwa E, Crean S, Ahmed W, Faheem A, Taylor KMG,. 2013. Air-jet and vibrating-mesh nebulization of niosomes generated using a particulate-based proniosome technology. Int J Pharm 444 (1-2): 193-199.
31. Fadda AM, Baroli BM, Maccioni AM, Siniso C, Valenti D, Alhaique F,. 1998. Phospholipid-detergent systems: Effects of polysorbates on the release of liposomal caffeine. Il Farmaco 53 (10-11): 650-654.
32. Serisier DJ, Bilton D, De Soyza A, Thompson PJ, Kolbe J, Greville HW, Cipolla D, Bruinenberg P, Gonda I,. 2013. Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): A randomised, double-blind, placebo-controlled trial. Thorax 68 (9): 812-817.